Clinical Scorecard: Evaluating the Use of a Collagen-Elastin Scaffold with Split-Thickness Skin Grafts for Full-Thickness Soft Tissue Defects: A Retrospective Cohort Analysis and Case Study

At a Glance

Key Highlights

• Matriderm® provides a 1.0 mm thick three-dimensional collagen and elastin matrix enabling single-step combination with split-thickness skin grafts.
• NPWT preconditioning reduces wound size, bacterial load, and edema, improving graft take and reducing donor and acceptor site morbidity.
• Positive bacterial cultures without clinical infection signs do not necessarily delay definitive wound closure with Matriderm®-augmented grafts.

Guideline-Based Recommendations

Diagnosis

• Assess wound type (fracture, open fracture, soft tissue injury) and extent of full-thickness defect.
• Perform microbiological sampling during initial debridement and sequential interventions to monitor bacterial load.

Management

• Use NPWT preoperatively to condition complex wounds, promote granulation tissue, and reduce bacterial bioburden.
• Apply Matriderm® matrix combined with split-thickness skin grafts in a one-step procedure once sufficient granulation and absence of clinical inflammation are confirmed.
• Administer intravenous broad-spectrum antibiotics initially in high-risk or infected wounds; use prophylactic single-shot antibiotics for clean wounds.

Monitoring & Follow-up

• Regular follow-up starting 2 weeks post-discharge, continuing for at least 8 weeks or up to 1 year.
• Monitor clinical signs of local inflammation (heat, pain, redness, swelling, loss of function) to guide timing of definitive closure.
• Track bacterial cultures and antibiotic sensitivity to adjust antimicrobial therapy.

Risks

• Potential for infection if wounds are closed prematurely without adequate granulation or control of bacterial load.
• Complications related to flap surgery avoided by using Matriderm®-augmented grafts, but donor and acceptor site morbidity still possible.
• Risk of graft detachment or infection reduced by postoperative epicutaneous NPWT.

Patient & Prescribing Data

Patients with full-thickness wounds requiring skin grafting, including those with open fractures and soft tissue injuries.

Broad-spectrum intravenous antibiotics are used initially in high-risk or infected wounds, with adjustments based on culture results; clean wounds receive prophylactic single-shot antibiotics prior to surgery.

Clinical Best Practices

• Perform multiple surgical debridements and irrigation with temporary NPWT in contaminated or inflamed wounds before definitive closure.
• Use Matriderm® matrix with split-thickness skin grafts in a single-step procedure once wound bed is adequately prepared.
• Employ postoperative epicutaneous NPWT for at least 5 days to enhance graft take and reduce infection risk.
• Do not delay closure solely based on positive bacterial cultures if clinical signs of infection are absent.

References

• STROBE guidelines